Ondansetron Tablet, Orally Disintegrating
Product Images NDC 85766-213

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 85766-213). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sportpharm Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Label)

Packaging label for Ondansetron Orally Disintegrating Tablets USP 4 mg by Sportpharm LLC. Displays relabeled and repackaged information with NDC codes 85766-213-30 (Qty 30) and 85766-213-10 (Qty 10). Distributed by Rising Pharma Holdings, Inc., with details on tablet description, batch numbers, and storage instructions.*

FDA Label Image

Chemical Structure (Ondansetronod Str)

Chemical structure of Ondansetron, showing its molecular framework including the indole moiety, ketone group, methyl, and methyl-substituted imidazole ring, corresponding to its verified generic identity.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.